Trends in Cardiovascular Medicine
Volume 19, Issue 1 , Pages 11-17, January 2009

Serine Carboxypeptidases in Regulation of Vasoconstriction and Elastogenesis

  • Alexey V. Pshezhetsky

      Affiliations

    • Department of Medical Genetics, CHU Sainte-Justine Research Center, Departments of Pediatrics and Biochemistry, University of Montreal, Montreal, Quebec, Canada, H3T 1C5
    • Department of Anatomy and Cell Biology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada, H3A 2B2
    • Corresponding Author InformationAddress correspondence to: Dr. Alexey V. Pshezhetsky, Department of Medical Genetics, CHU Sainte-Justine, 3175 Côte Ste-Catherine, Montreal (Qc),Canada H3T 1C5. Tel.: (+1) 514-345-4931/2736; fax: (+1) 514-345-4766.
  • ,
  • Aleksander Hinek

      Affiliations

    • Physiology and Experimental Medicine Program in The Hospital for Sick Children, Toronto, Ontario, Canada
    • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, M5G 1X8

Lysosomal carboxypeptidases play important roles in catabolism of proteins and peptides and in posttranslational processing of other lysosomal enzymes. The major lysosomal serine carboxypeptidase A (cathepsin A [CathA]), also known as protective protein, activates and stabilizes two other lysosomal enzymes, β-galactosidase and neuraminidase/sialidase 1. Genetic deficiency of CathA (galactosialidosis) causes the lysosomal storage of sialylated glycoconjugates and leads to a multiorgan pathology. The galactosialidosis patients also show arterial hypertension and cardiomyopathy, conditions not predicted from the lysosomal storage of glycoconjugates. This review summarizes the experimental data suggesting that both cardiovascular pathologies associate with persisted vasoconstrictions and impaired formation of the elastic fibers triggered by the deficiency of CathA. We also discuss the homologous serine carboxypeptidases, Scpep1 and vitellogenic-like carboxypeptidase, that are secreted from endothelial cells and could potentially affect the cardiovascular system.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported in part by the operating grants from Canadian Institutes of Health Research to AVP and AH and by the operating grant from the Heart and Stroke Foundation of Ontario to AH.

PII: S1050-1738(09)00052-8

doi:10.1016/j.tcm.2009.03.002

Trends in Cardiovascular Medicine
Volume 19, Issue 1 , Pages 11-17, January 2009